Soleno Therapeutics Announces VYKAT(TM) XR Launch
April 14, 2025
First prescriptions delivered to individuals with PWS Soleno Therapeutics, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced the U.S.